102 related articles for article (PubMed ID: 24720676)
1. Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival.
Araz O; Ucar EY; Meral M; Yalcin A; Acemoglu H; Dogan H; Karaman A; Aydin Y; Gorguner M; Akgun M
Clin Respir J; 2015 Jul; 9(3):297-304. PubMed ID: 24720676
[TBL] [Abstract][Full Text] [Related]
2. Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancer.
Bulut I; Meral M; Kaynar H; Pirim I; Bilici M; Gorguner M
Lung Cancer; 2009 Nov; 66(2):231-6. PubMed ID: 19246116
[TBL] [Abstract][Full Text] [Related]
3. Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.
Gamzatova Z; Villabona L; van der Zanden H; Haasnoot GW; Andersson E; Kiessling R; Seliger B; Kanter L; Dalianis T; Bergfeldt K; Masucci GV
Tissue Antigens; 2007 Sep; 70(3):205-13. PubMed ID: 17661908
[TBL] [Abstract][Full Text] [Related]
4. [Study on the relationship between chronic glomerulonephritis and human leukocyte antigen in Shandong province].
Zhao JJ; Liu JL; Zhang C
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):1030-5. PubMed ID: 18399156
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
[TBL] [Abstract][Full Text] [Related]
6. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigens class I and class II in patients with pemphigus in southern Turkey.
Koc CK; Sallakci N; Akman-Karakaş A; Alpsoy E; Yegin O
Int J Dermatol; 2013 Jan; 52(1):53-8. PubMed ID: 23278608
[TBL] [Abstract][Full Text] [Related]
8. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
9. HLA alleles and lung cancer in a Turkish population.
Ozbek N; Birinci A; Karaoglanoglu O; Coban AY; Okumus B; Cakir S; Durupinar B
Ann Saudi Med; 2004; 24(2):106-11. PubMed ID: 15323271
[TBL] [Abstract][Full Text] [Related]
10. Spatial Analysis and Clinical Significance of HLA Class-I and Class-II Subunit Expression in Non-Small Cell Lung Cancer.
Datar IJ; Hauc SC; Desai S; Gianino N; Henick B; Liu Y; Syrigos K; Rimm DL; Kavathas P; Ferrone S; Schalper KA
Clin Cancer Res; 2021 May; 27(10):2837-2847. PubMed ID: 33602682
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan.
Nagata Y; Hanagiri T; Mizukami M; Kuroda K; Shigematsu Y; Baba T; Ichiki Y; Yasuda M; So T; Takenoyama M; Sugio K; Nagashima A; Yasumoto K
Lung Cancer; 2009 Jul; 65(1):91-7. PubMed ID: 19054590
[TBL] [Abstract][Full Text] [Related]
12. Immunogenetic aspects of erosive osteoarthritis of the hand in patients from northern Italy.
Ramonda R; Musacchio E; Campana C; Frigato M; Frallonardo P; Barbieri V; Piccoli A; Valvason C; Bronte V; Zanovello P; Punzi L
Scand J Rheumatol; 2011 Mar; 40(2):139-44. PubMed ID: 20919945
[TBL] [Abstract][Full Text] [Related]
13. HLA class I and class II genotyping in patients with chronic urticaria.
Coban M; Erdem T; Ozdemir S; Pirim I; Atasoy M; Ikbal M
Int Arch Allergy Immunol; 2008; 147(2):135-9. PubMed ID: 18520158
[TBL] [Abstract][Full Text] [Related]
14. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
[TBL] [Abstract][Full Text] [Related]
15. The frequency of HLA class I and II alleles in Turkish childhood acute leukaemia patients.
Ozdilli K; Oguz FS; Anak S; Kekik C; Carin M; Gedikoglu G
J Int Med Res; 2010; 38(5):1835-44. PubMed ID: 21309500
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen (HLA) class I and II alleles in Turkish patients with rheumatic heart disease.
Gündogdu F; Islamoglu Y; Pirim I; Gurlertop Y; Dogan H; Arslan S; Sevimli S; Aksakal E; Senocak H
J Heart Valve Dis; 2007 May; 16(3):293-9. PubMed ID: 17578051
[TBL] [Abstract][Full Text] [Related]
17. Loss of HLA haplotype in lung cancer cell lines: implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer.
Hiraki A; Kaneshige T; Kiura K; Ueoka H; Yamane H; Tanaka M; Harada M
Clin Cancer Res; 1999 Apr; 5(4):933-6. PubMed ID: 10213231
[TBL] [Abstract][Full Text] [Related]
18. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease.
Grubić Z; Zunec R; Peros-Golubicić T; Tekavec-Trkanjec J; Martinez N; Alilović M; Smojver-Jezek S; Kerhin-Brkljacić V
Tissue Antigens; 2007 Oct; 70(4):301-6. PubMed ID: 17767551
[TBL] [Abstract][Full Text] [Related]
19. Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
Tan X; Wu Q; Cai Y; Zhao X; Wang S; Gao Z; Yang Y; Li X; Qian J; Wang J; Su B; Chen H; Han B; Jiang G; Lu D
Clin Lung Cancer; 2014 Jan; 15(1):67-78.e12. PubMed ID: 24220096
[TBL] [Abstract][Full Text] [Related]
20. A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911.
Yamada K; Aono H; Hosomi Y; Okamoto H; Kato T; Komase Y; Nishikawa M; Azuma K; Takeoka H; Okuma Y; Nakahara Y; Sato A; Oba MS; Morita S; Kunitoh H; Watanabe K
Eur J Cancer; 2015 Sep; 51(14):1904-10. PubMed ID: 26174465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
